HHRI News & Press Releases
HIV, Hepatitis B & C
Our Research Home » Our Research » HIV, Hepatitis B & C Dr. Noska’s research interests focus on clinical trials that evaluate new therapeutic agents for Hepatitis B and HIV. She investigates the social determinants of health influencing the care for persons living with HIV, HCV, and/or HBV, and comorbid…
Read MoreNephrology, Transplantation, & Health Disparities
Our Research Home » Our Research » Nephrology, Transplantation, & Health Disparities Dr. McKinney’s interests lie in researching the cause of disparities in access to kidney transplantation, evaluating patient-level barriers and facilitators to transplantation, and developing support interventions for patients and families. One of his current focuses is the joint…
Read More
Dr. Burrack Bound for Homeward Bound
Growing up, Kristina Burrack, PhD, was always on the move. She was fascinated by the outdoors, loved hands-on learning, and played college athletics. Dr. Burrack loved doing science labs and knew she wanted to be a biology major in college. While at St. Olaf College, she became passionate about immunology…
Read MoreSTIs, HIV Prevention
Our Research Home » Our Research » STIs, HIV Prevention STIs, HIV Prevention, Clinical Trials, Behavioral Science Jenell Stewart, DO, MPH, is an Infectious Diseases physician-scientist focused on the prevention of Sexually Transmitted Infections (STIs) and Human Immunodeficiency Virus (HIV) and improving clinical care for women who engage in transactional…
Read More
Doxycycline does not prevent STIs among cisgender women
Researchers from the University of Washington (UW), Kenya Medical Research Institute (KEMRI), and Hennepin Healthcare Research Institute (HHRI) announced results at CROI from a clinical trial demonstrating that doxycycline taken after sex does not prevent bacterial sexually transmitted infections (STIs) – chlamydia or gonorrhea – among cisgender women. The dPEP…
Read More
HHRI investigators highlighted by CTSI as UMN Mothers Leading Science
Hennepin Healthcare Research Institute (HHRI) investigators Anne Frosch, MD, MPH, and Sandra Japuntich, PhD, LP, were featured in the University of Minnesota’s Clinical & Translational Science Institute (CTSI) news welcoming the fourth cohort of researcher-moms into Mothers Leading Science, a yearlong career development program for research-intensive faculty in the health sciences…
Read More
Thank you to Dr. Jason Baker for his exceptional dedication and service as HHRI Vice President
Jason Baker, MD, MS, recently stepped down as Vice President of Hennepin Healthcare Research Institute (HHRI). Dr. Baker began his tenure as VP in January 2015 when the institute was the Minneapolis Medical Research Foundation and served in the role until December 2021. During this time, Dr. Baker was instrumental…
Read More
Hennepin Healthcare launches two clinical trials to study the investigational antiviral drug remdesivir to treat hospitalized patients with COVID-19
Minneapolis, Minn. – April 9, 2020 – The Hennepin Healthcare Research Institute (HHRI) has launched two clinical trials to study the safety and efficacy of remdesivir to treat hospitalized patients diagnosed with moderate or severe COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. Hennepin Healthcare is a clinical site…
Read More